Category: All our news

All our news

XenTech exhibits at EACR 2022 (Seville, Jun. 20-23 2022)

We’ll be exhibiting at EACR in Seville, stop by booth #50 !

triangleDiscover
Publications

Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification

triangleDiscover
Publications

Targeting genome integrity dysfunctions impedes metastatic potency in non-small-cell lung cancer circulating tumor cellderived eXplants

CTC-derived eXplants (CDX) offer systems for mechanistic investigation of CTC metastatic potency and may provide rationale for biology-driven therapeutics.

triangleDiscover
All our news

XenTech exhibits at AACR Annual Meeting (New Orleans, Apr.8-13 2022)

We’ll be exhibiting at AACR New Orleans from Apr.8th 2022, stop by our booth to chat with us (at last!)

triangleDiscover
Publications

STING protects breast cancer cells from intrinsic and genotoxic-induced DNA instability via a non-canonical, cell-autonomous pathway – Oncogene, Oct.8 2021

triangleDiscover
Publications

Paediatric Liver Cancer

A preclinical platform of mouse-transplanted human pediatric liver tumors to evaluate the efficacy of conventional and innovative anticancer therapy

triangleDiscover
Publications

Paediatric Liver Cancer

Liver cancer patient-derived xenografts to improve disease management in childhood and adolescence: perspectives and challenges of personalized medicine

triangleDiscover
Publications

Paediatric Liver Cancer

A panel of pediatric liver cancer patient-derived xenografts to improve stratification of children with hepatoblastoma

triangleDiscover
Publications

2D PDX-derived primary cultures

A new and fast in vitro screen to predict in vivo drug efficacy using cell primary culture from patient derived tumor established xenografts

triangleDiscover
Publications

Liver Cancer

Myc Target miRs and Liver Cancer: Small Molecules to Get Myc Sick

triangleDiscover